Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis

doi:10.5312/wjo.v17.i1.111911

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

(40)

(33)

(0)

(11)

(1822)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Orthop. Jan 18, 2026; 17(1): 111911
Published online Jan 18, 2026. doi: 10.5312/wjo.v17.i1.111911

Full Size Figure Download Figure

Figure 2 Molecular hydrogen -mediated nuclear factor erythroid 2-related factor 2/Kelch-like ECH associated protein 1 signaling pathway. Keap1: Kelch-like ECH-associated protein 1; Nrf2: Nuclear factor erythroid 2-related factor 2; sMaf: Small Maf protein; ARE: Antioxidant response element.

Citation: Jeyaraman N, Jeyaraman M, Ramasubramanian S, Murugan S, Nallakumarasamy A, Muthu S. Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis. World J Orthop 2026; 17(1): 111911
URL: https://www.wjgnet.com/2218-5836/full/v17/i1/111911.htm
DOI: https://dx.doi.org/10.5312/wjo.v17.i1.111911

Jeyaraman N, Jeyaraman M, Ramasubramanian S, Murugan S, Nallakumarasamy A, Muthu S. Molecular hydrogen therapy in musculoskeletal conditions: An evidence-based review and critical analysis. World J Orthop 2026; 17(1): 111911 [PMID: 41608485 DOI: 10.5312/wjo.v17.i1.111911]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.